GB virus C: the good boy virus?

[1]  J. McLinden,et al.  GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression. , 2012, The Journal of infectious diseases.

[2]  T. Mekhail,et al.  Interleukin-2 in Cancer Therapy , 2000, BioDrugs.

[3]  A. Kelleher,et al.  Role of Interleukin-2 in Patients with HIV Infection , 2012, Drugs.

[4]  B. Cowie,et al.  Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. , 2011, Journal of hepatology.

[5]  K. Hristova,et al.  Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C. , 2011, Journal of colloid and interface science.

[6]  B. Fleckenstein,et al.  Peptides Derived from a Distinct Region of GB Virus C Glycoprotein E2 Mediate Strain-Specific HIV-1 Entry Inhibition , 2011, Journal of Virology.

[7]  Jack T. Stapleton,et al.  The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae , 2011, The Journal of general virology.

[8]  D. Montefiori,et al.  GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates , 2010, The Journal of Immunology.

[9]  B. Clotet,et al.  GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4+ T-cells , 2010, Antiviral therapy.

[10]  K. Chaloner,et al.  GB virus C infection and non‐Hodgkin lymphoma: important to know but the jury is out , 2010, International journal of cancer.

[11]  J. McLinden,et al.  Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1 , 2009, The Journal of Immunology.

[12]  E. Sabino,et al.  GB virus type C infection modulates T-cell activation independently of HIV-1 viral load , 2009, AIDS.

[13]  J. Stapleton,et al.  GB virus type C interactions with HIV: the role of envelope glycoproteins , 2009, Journal of viral hepatitis.

[14]  H. Lane,et al.  Interleukin-2 therapy in patients with HIV infection. , 2009, The New England journal of medicine.

[15]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[16]  K. Chaloner,et al.  GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy , 2009, AIDS.

[17]  H. Tillmann,et al.  GBV‐C coinfection is negatively correlated to Fas expression and Fas‐mediated apoptosis in HIV‐1 infected patients , 2008, Journal of medical virology.

[18]  R. Kaul,et al.  Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. , 2008, The Journal of infectious diseases.

[19]  B. Haynes,et al.  HIV-1 hides an Achilles' heel in virion lipids. , 2008, Immunity.

[20]  A. Vitale,et al.  Activation of Interferon Response Genes and of Plasmacytoid Dendritic Cells in HIV-1 Positive Subjects with GB Virus C Co-Infection , 2008, International journal of immunopathology and pharmacology.

[21]  J. McLinden,et al.  Expression of GB virus C NS5A protein from genotypes 1, 2, 3 and 5 and a 30 aa NS5A fragment inhibit human immunodeficiency virus type 1 replication in a CD4+ T-lymphocyte cell line. , 2007, The Journal of general virology.

[22]  R. D. de Boer,et al.  Do Most Lymphocytes in Humans Really Reside in the Gut? , 2022 .

[23]  R. Hershow,et al.  Impact of GB virus type C infection on mother‐to‐child HIV transmission in the Women and Infants Transmission Study Cohort , 2007, HIV medicine.

[24]  Y. Sun,et al.  Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells , 2007, PloS one.

[25]  F. Neipel,et al.  HIV entry inhibition by the envelope 2 glycoprotein of GB virus C , 2007, AIDS.

[26]  J. McLinden,et al.  An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells , 2006, Proceedings of the National Academy of Sciences.

[27]  M. Lederman,et al.  Biology of CCR5 and its role in HIV infection and treatment. , 2006, JAMA.

[28]  F. Poccia,et al.  Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients. , 2006, Cellular and molecular biology.

[29]  K. Chaloner,et al.  Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.

[30]  Martin Meier-Schellersheim,et al.  Pathogenesis of HIV infection: what the virus spares is as important as what it destroys , 2006, Nature Medicine.

[31]  J. Stapleton,et al.  GB virus C replicates in primary T and B lymphocytes. , 2006, The Journal of infectious diseases.

[32]  K. Chaloner,et al.  Effect of GB virus C on response to antiretroviral therapy in HIV‐infected Brazilians * , 2006, HIV medicine.

[33]  P. Lebon,et al.  Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. , 2005, The Journal of infectious diseases.

[34]  H. Schuitemaker,et al.  GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. , 2005, The Journal of infectious diseases.

[35]  John P. Moore,et al.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.

[36]  S. Wünschmann,et al.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1 , 2004, The Lancet.

[37]  L. Yee,et al.  Host genetic determinants in hepatitis C virus infection , 2004, Genes and Immunity.

[38]  J. Margolick,et al.  Persistent GB virus C infection and survival in HIV-infected men. , 2004, The New England journal of medicine.

[39]  J. Stapleton,et al.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. , 2004, Lancet.

[40]  J. Stapleton,et al.  Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. , 2003, Virology.

[41]  A. Chiocchetti,et al.  Role of FAS in HIV infection. , 2003, Current HIV research.

[42]  J. Nattermann,et al.  Regulation of CC chemokine receptor 5 in Hepatitis G virus infection , 2003, AIDS.

[43]  H. Doerr,et al.  Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile , 2003, Annals of Internal Medicine.

[44]  J. Alimonti,et al.  Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. , 2003, The Journal of general virology.

[45]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[46]  J. Stapleton.  GB Virus Type C/Hepatitis G Virus , 2003, Seminars in liver disease.

[47]  M. Lederman,et al.  Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. , 2003, The Journal of infectious diseases.

[48]  Andre E Nel,et al.  T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. , 2002, The Journal of allergy and clinical immunology.

[49]  R. Paredes,et al.  The potential role of interleukin-2 in patients with HIV infection. , 2002, AIDS reviews.

[50]  P. Fitzgerald-Bocarsly,et al.  Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. , 2001, Clinical immunology.

[51]  B. Gazzard,et al.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. , 2001, Blood.

[52]  M. Manns,et al.  Infection with GB virus C and reduced mortality among HIV-infected patients. , 2001, The New England journal of medicine.

[53]  S. Wünschmann,et al.  Effect of coinfection with GB virus C on survival among patients with HIV infection. , 2001, The New England journal of medicine.

[54]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[55]  J. Levy,et al.  The importance of the innate immune system in controlling HIV infection and disease. , 2001, Trends in immunology.

[56]  B. Spellberg,et al.  Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  J. Stapleton,et al.  Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infectious in Primary CD4-Positive T Cells , 2000, Journal of Virology.

[58]  A E Yeo,et al.  Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia , 2000, Annals of Internal Medicine.

[59]  C. Payá,et al.  Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. , 1999, AIDS research and human retroviruses.

[60]  J. Tschopp,et al.  Dynamic correlation of apoptosis and immune activation during treatment of HIV infection , 1999, Cell Death and Differentiation.

[61]  F. Roudot-thoraval,et al.  Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. , 1999, The Journal of infectious diseases.

[62]  M. Manns,et al.  GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.

[63]  D. Vlahov,et al.  Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. , 1998, The Journal of infectious diseases.

[64]  J. Takamatsu,et al.  Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[65]  F. Masiarz,et al.  Hepatitis G Virus Encodes Protease Activities Which Can Effect Processing of the Virus Putative Nonstructural Proteins , 1998, Journal of Virology.

[66]  S. Sauleda,et al.  Humoral immune response to the E2 protein of hepatitis G virus is associated with long‐term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors , 1997, Hepatology.

[67]  G. Noel,et al.  Endogenous interleukin-2 serum levels in children infected with human immunodeficiency virus. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  H. Sekihara,et al.  Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. , 1997, Biochemical and biophysical research communications.

[69]  H. Alter.  G‐pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus , 1997, Transfusion.

[70]  S. Lemon,et al.  GB virus C, hepatitis G virus, or human orphan flavivirus? , 1997, Hepatology.

[71]  J. Rosenblatt,et al.  Prevalence studies of GB Virus‐C infection using reverse transcriptase‐polymerase chain reaction , 1996, Journal of medical virology.

[72]  M. Moroni,et al.  Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. , 1996, Blood.

[73]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[74]  T. Pilot‐Matias,et al.  Sequence and genomic organization of GBV‐C: A novel member of the flaviviridae associated with human non‐A‐E hepatitis , 1996, Journal of medical virology.

[75]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[76]  T. Curiel,et al.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.

[77]  A. Lazzarin,et al.  TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV‐infected patients , 1994, AIDS.

[78]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.